Related Experiment Video
Updated: May 2, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
The invasive assessment of coronary atherosclerosis and stents using optical coherence tomography: a clinical update
Muhammad Asrar Ul Haq1, Jamie Layland2, Vivek Mutha1
1Department of Medicine , University of Melbourne , Melbourne , Australia ; Department of Cardiology , The Northern Hospital , Melbourne , Australia.
Insights
Optical coherence tomography (OCT) provides high-resolution imaging of coronary arteries. This technology aids in assessing vulnerable plaques and optimizing stent implantation for improved patient outcomes in ischaemic heart disease.
Area of Science:
- Cardiovascular Medicine
- Medical Imaging
- Biomedical Engineering
Background:
- Ischaemic heart disease (IHD) is a major global cause of mortality.
- Atherosclerosis, a key contributor to IHD, necessitates advanced diagnostic tools.
- Current imaging techniques have limitations in visualizing coronary plaque morphology and tissue response post-stenting.
Purpose of the Study:
- To highlight the role of optical coherence tomography (OCT) in characterizing coronary atherosclerotic plaque.
- To explore OCT's utility in evaluating tissue responses after coronary stent implantation.
- To demonstrate OCT's potential in assessing vulnerable plaque features and guiding therapeutic decisions.
Main Methods:
- Utilizes optical coherence tomography (OCT), an invasive, light-based intracoronary imaging modality.
- Employs near-infrared light for imaging with a 15-micron resolution, surpassing other intravascular techniques.
- Enables detailed visualization of coronary artery lumen and wall structures in vivo.
Main Results:
- OCT allows for comprehensive detection of vulnerable plaque characteristics, such as large lipid pools and thin fibrous caps.
- The technology facilitates assessment of optimal stent deployment within the coronary artery.
- OCT visualizes neointimal tissue formation over stent surfaces, offering potential surrogate markers for stent safety.
Conclusions:
- Optical coherence tomography (OCT) is a valuable tool for in vivo characterization of coronary atherosclerosis and stent response.
- OCT imaging can identify high-risk plaque features and assess stent implantation adequacy.
- This technology may inform decisions regarding dual antiplatelet therapy duration for improved long-term stent safety.
Abstract:
Ischaemic heart disease (IHD) remains one of the leading causes of death. Atherosclerosis has been intensely researched given the IHD prevalence and the financial impacts on healthcare systems. More recently, in vivo characterisation of coronary atherosclerotic plaque and tissue responses following stent implantation in a coronary artery has been made possible by a novel technology called optical coherence tomography (OCT). OCT is a light-based, invasive, intracoronary imaging modality long applied to the field of ophthalmology and now in clinical use worldwide. It gives a unique view of within the coronary artery using near-infrared light with a resolution of 15 microns, 10 times higher than other invasive coronary imaging techniques like intravascular ultrasound. The technology is being adopted to comprehensively detect features that make plaques 'vulnerable' (eg, large lipid pool, thin, fibrous-cap atheroma), whether stents are implanted optimally within the artery, and visualise the small layers of tissue that form over stent metal surfaces over time, which in turn may provide surrogate markers for long-term stent safety and help guide the optimal duration of dual antiplatelet therapy, a topic of big discussion at the current point of time.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Imaging Studies for Cardiovascular System V: CT
Coronary Artery Disease I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

